New Therapeutic Insights on HIV Management in Uganda with Lenacapavir
A study from Weill Cornell Medicine found no significant resistance to the new HIV drug lenacapavir among Ugandan patients. Only 1.6% had mutations associated with resistance, indicating potential widespread effectiveness. …
New Therapeutic Insights on HIV Management in Uganda with Lenacapavir Read More